Different anthracycline derivates for reducing cardiotoxicity in cancer patients.

MLA

van Dalen, Elvira C., et al. “Different Anthracycline Derivates for Reducing Cardiotoxicity in Cancer Patients.” The Cochrane Database of Systematic Reviews, no. 5, May 2010, p. CD005006. EBSCOhost, https://doi.org/10.1002/14651858.CD005006.pub4.

APA

van Dalen, E. C., Michiels, E. M., Caron, H. N., & Kremer, L. C. (2010). Different anthracycline derivates for reducing cardiotoxicity in cancer patients. The Cochrane Database of Systematic Reviews, 5, CD005006. https://doi.org/10.1002/14651858.CD005006.pub4

Chicago

van Dalen, Elvira C, Erna Mc Michiels, Huib N Caron, and Leontien Cm Kremer. 2010. “Different Anthracycline Derivates for Reducing Cardiotoxicity in Cancer Patients.” The Cochrane Database of Systematic Reviews, no. 5 (May): CD005006. doi:10.1002/14651858.CD005006.pub4.